Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to do a Bitmine stock analysis & discuss the risks and upside potential of BMNR stock

1 extracted signal · 0 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
31 Mar 2026, 22:19 UTC
Recorded by Tahlil Plus
18 May 2026, 20:24 UTC
Video preview for Friends! In this video, I'm going to do a Bitmine stock analysis & discuss the risks and upside potential of BMNR stock
Source overview

AI-generated source summary

The speaker discusses Bitmine Immersion Technologies Inc. (BMRN) and its stock performance in relation to Ethereum (ETH) and Bitcoin (BTC). BMRN has seen a significant decline, while ETH and BTC have experienced drawdowns followed by recoveries. The analysis highlights that BMRN's stock price is correlated with ETH's price, and the company's strategy of issuing stock to acquire ETH is seen as a potential catalyst for future growth, especially as dilution might be nearing an end. The speaker believes ETH is currently undervalued based on its historical ratio with BTC and that reaching $12k-$22k ETH price levels could significantly boost BMRN's stock value. The speaker expresses confidence in BMRN's future performance due to its valuation, revenue potential from ETH staking, and the reach of Mr. Beast's influence.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
1
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail